2GY Stock Overview
Through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
PHC Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥6.20 |
| 52 Week High | JP¥9.50 |
| 52 Week Low | JP¥5.70 |
| Beta | 0.78 |
| 11 Month Change | 5.98% |
| 3 Month Change | -13.29% |
| 1 Year Change | -30.73% |
| 33 Year Change | -65.05% |
| 5 Year Change | n/a |
| Change since IPO | -70.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2GY | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 8.8% | 2.4% | 0.8% |
| 1Y | -30.7% | -5.0% | 9.1% |
Return vs Industry: 2GY underperformed the German Medical Equipment industry which returned -5% over the past year.
Return vs Market: 2GY underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| 2GY volatility | |
|---|---|
| 2GY Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2GY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2GY's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 9,245 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, through its subsidiaries, offers medical devices, healthcare IT solutions, and life science products and services primarily in Japan. It operates through Diabetes Management, Healthcare Solutions, and Diagnostic & Life Sciences segments. The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record system, electronic medication history system, and healthcare note service; and diagnostic testing products, which include clinical testing, diagnostic reagents and instruments, and drug development support products.
PHC Holdings Corporation Fundamentals Summary
| 2GY fundamental statistics | |
|---|---|
| Market cap | €801.49m |
| Earnings (TTM) | -€39.51m |
| Revenue (TTM) | €2.25b |
0.4x
P/S Ratio-20.3x
P/E RatioIs 2GY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2GY income statement (TTM) | |
|---|---|
| Revenue | JP¥360.94b |
| Cost of Revenue | JP¥196.83b |
| Gross Profit | JP¥164.11b |
| Other Expenses | JP¥170.45b |
| Earnings | -JP¥6.34b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -50.23 |
| Gross Margin | 45.47% |
| Net Profit Margin | -1.76% |
| Debt/Equity Ratio | 211.0% |
How did 2GY perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield-36%
Payout RatioDoes 2GY pay a reliable dividends?
See 2GY dividend history and benchmarks| PHC Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 19 2024 |
| Days until Ex dividend | 61 days |
| Days until Dividend pay date | 22 days |
Does 2GY pay a reliable dividends?
See 2GY dividend history and benchmarks